Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
CALL
iShares Gold Trust
IAU
$64.9B
| $12.8M | ﹤0.01% |
259,400
+35,200
| +16% | +$1.77M |
|
2627
Xenon Pharmaceuticals
XENE
$6.03B
| $12.8M | ﹤0.01% |
327,303
-395,201
| -55% | -$16.3M |
|
2628
CareTrust REIT
CTRE
$9.16B
| $12.8M | ﹤0.01% |
473,259
+464,611
| +5,372% | +$13.9M |
|
2629
iShares ESG Aware MSCI EM ETF
ESGE
$6.84B
| $12.8M | ﹤0.01% |
382,882
+353,083
| +1,185% | +$12.5M |
|
2630
Acrivon Therapeutics
ACRV
$83.6M
| $12.8M | ﹤0.01% |
2,119,646
-20,982
| -1% | -$152K |
|
2631
PUT
Bitdeer Technologies
BTDR
$2.48B
| $12.8M | ﹤0.01% |
588,800
+463,000
| +368% | +$5.89M |
|
2632
PUT
Check Point Software Technologies
CHKP
$13.4B
| $12.8M | ﹤0.01% |
68,300
-1,100
| -2% | -$207K |
|
2633
ProShares Ultra S&P500
SSO
$8.47B
| $12.8M | ﹤0.01% |
275,654
-112,468
| -29% | -$5.3M |
|
2634
CALL
McCormick & Company Non-Voting
MKC
$14.7B
| $12.7M | ﹤0.01% |
167,000
-30,900
| -16% | -$2.43M |
|
2635
The Ensign Group
ENSG
$10.6B
| $12.7M | ﹤0.01% |
95,726
-38,126
| -28% | -$5.54M |
|
2636
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.94B
| $12.7M | ﹤0.01% |
437,607
+310,933
| +245% | +$9.69M |
|
2637
TC Energy
TRP
$66.7B
| $12.7M | ﹤0.01% |
273,027
-126,293
| -32% | -$5.97M |
|
2638
PUT
SolarEdge
SEDG
$1.99B
| $12.7M | ﹤0.01% |
934,000
-451,200
| -33% | -$6.94M |
|
2639
CALL
Liberty Latin America Class C
LILAK
$1.66B
| $12.7M | ﹤0.01% |
2,201,210
-440
| -0% | -$3.19K |
|
2640
CALL
iShares Core S&P Mid-Cap ETF
IJH
$129B
| $12.7M | ﹤0.01% |
203,600
+84,900
| +72% | +$5.45M |
|
2641
PUT
Entegris
ENTG
$24.7B
| $12.7M | ﹤0.01% |
128,000
-43,700
| -25% | -$4.61M |
|
|
JWN
2642
PUT
DELISTED
Nordstrom
JWN
| $12.7M | ﹤0.01% |
524,600
+6,900
| +1% | +$159K |
|
2643
CALL
AeroVironment
AVAV
$9.76B
| $12.7M | ﹤0.01% |
82,300
+11,900
| +17% | +$2.33M |
|
2644
PUT
NetEase
NTES
$80.1B
| $12.6M | ﹤0.01% |
141,700
-61,100
| -30% | -$5.35M |
|
2645
Rocket Lab Corp
RKLB
$51.3B
| $12.6M | ﹤0.01% |
496,305
-2,654,770
| -84% | -$46.6M |
|
2646
Valmont Industries
VMI
$9.56B
| $12.6M | ﹤0.01% |
41,218
-50,923
| -55% | -$16.4M |
|
2647
CALL
Molina Healthcare
MOH
$11.1B
| $12.6M | ﹤0.01% |
43,400
-52,000
| -55% | -$16.1M |
|
2648
Ardelyx
ARDX
$1.05B
| $12.6M | ﹤0.01% |
2,490,618
+281,685
| +13% | +$1.56M |
|
2649
PUT
WillScot Mobile Mini Holdings
WSC
$4.31B
| $12.6M | ﹤0.01% |
377,500
+246,400
| +188% | +$9.05M |
|
|
FITB
2650
CALL
Fifth Third Bancorp
FITB
$52.7B
| $12.6M | ﹤0.01% |
298,300
+1,700
| +0.6% | +$76.3K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.